Background: Improving health-related quality of life is a primary target of therapy for patients with inflammatory bowel disease. Physical activity has been demonstrated to improve health-related quality of life in several patient populations with chronic disease. There are very few studies investigating the effects of physical activity on health-related quality of life in inflammatory bowel disease. The primary purpose of this study is to investigate the effects of 10 weeks of moderate physical activity on health-related quality of life in patients with inflammatory bowel disease. Methods: Thirty patients with mild to moderate IBD (Crohn‘s Disease Activity Index (CDAI) <220 or Rachmilewitz Index (RI) <11) were randomized 1:1 to either supervised moderate-intensity running thrice a week for 10 weeks or a control group who were not prescribed any exercise. Health-related quality of life, symptoms, and inflammation were assessed at baseline and after 10 weeks. Results: Participants were 41 ± 14 years (73% female), had a body mass index of 22.8 ± 4.1 kg/m2, and an average CDAI or RI of 66.8 ± 42.4 and 3.6 ± 3.1. No adverse events occurred during the 10-week training period. Health-related quality of life, reported as IBDQ total score, improved 19% in the intervention group and 8% in the control group. Scores for the IBDQ social sub-scale were significantly improved in the intervention group compared with controls (ΔIBDQsocial = 6.27 ± 5.46 vs. 1.87 ± 4.76, p = 0.023). Conclusion: Patients suffering from moderately active IBD are capable of performing symptom-free regular endurance exercise. Our data support the assumption that PA is feasible in IBD patients. PA may furthermore improve quality of life through improvements in social well-being, and may, therefore, be a useful adjunct to IBD therapy.

1.
Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B: Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005;11:909-918.
[PubMed]
2.
Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG, van Deursen C, Hameeteman WH, Pierik M, Wolters F, Russel MG, Stockbrügger RW: Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010;16:2137-2147.
[PubMed]
3.
Kunz JH, Hommel KA, Greenley RN: Health-related quality of life of youth with inflammatory bowel disease: a comparison with published data using the PedsQL 4.0 generic core scales. Inflamm Bowel Dis 2010;16:939-946.
[PubMed]
4.
Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS: Risk factors for depression in the elderly inflammatory bowel disease population. J Crohns Colitis 2014;8:113-119.
[PubMed]
5.
Fuller-Thomson E, Sulman J: Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006;12:697-707.
[PubMed]
6.
Bandzar S, Gupta S, Platt MO: Crohn's disease: a review of treatment options and current research. Cell Immunol 2013;286:45-52.
[PubMed]
7.
Cohen LB, Nanau RM, Delzor F, Neuman MG: Biologic therapies in inflammatory bowel disease. Transl Res 2014;163:533-556.
[PubMed]
8.
Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of Gastroenterology: Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010;105:501-523.
[PubMed]
9.
Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology: Management of Crohn's disease in adults. Am J Gastroenterol 2009;104:465-483.
[PubMed]
10.
Hilsden RJ, Scott CM, Verhoef MJ: Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol 1998;93:697-701.
[PubMed]
11.
Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B: Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med 2006;6:19.
[PubMed]
12.
Langhorst J, Anthonisen IB, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, Dobos GJ: Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis 2005;11:287-295.
[PubMed]
13.
Langhorst J, Anthonisen IB, Steder-Neukamm U, Luedtke R, Spahn G, Michalsen A, Dobos GJ: Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use. Complement Ther Med 2007;15:30-37.
[PubMed]
14.
Zou LY, Yang L, He XL, Sun M, Xu JJ: Effects of aerobic exercise on cancer-related fatigue in breast cancer patients receiving chemotherapy: a meta-analysis. Tumour Biol 2014;35:5659-5667.
[PubMed]
15.
Courneya KS, Segal RJ, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Jespersen D, Cook D, Proulx C, Trinh L, Dolan LB, Wooding E, Forbes CC, McKenzie DC: Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial. Breast Cancer Res Treat 2014;144:361-369.
[PubMed]
16.
Piña IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ; American Heart Association Committee on exercise, rehabilitation, and prevention: Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 2003;107:1210-1225.
[PubMed]
17.
Edelmann F, Gelbrich G, Düngen HD, Fröhling S, Wachter R, Stahrenberg R, Binder L, Töpper A, Lashki DJ, Schwarz S, Herrmann-Lingen C, Löffler M, Hasenfuss G, Halle M, Pieske B: Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 2011;58:1780-1791.
[PubMed]
18.
Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, McMurdo M, Mead GE: Exercise for depression. Cochrane Database Syst Rev 2013;9:CD004366.
[PubMed]
19.
Pérez CA: Prescription of physical exercise in Crohn's disease. J Crohns Colitis 2009;3:225-231.
[PubMed]
20.
Wiroth JB, Filippi J, Schneider SM, Al-Jaouni R, Horvais N, Gavarry O, Bermon S, Hébuterne X: Muscle performance in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis 2005;11:296-303.
[PubMed]
21.
Ploeger HE, Takken T, Wilk B, Issenman RM, Sears R, Suri S, Timmons BW: Exercise capacity in pediatric patients with inflammatory bowel disease. J Pediatr 2011;158:814-819.
[PubMed]
22.
Bilski J, Brzozowski B, Mazur-Bialy A, Sliwowski Z, Brzozowski T: The role of physical exercise in inflammatory bowel disease. Biomed Res Int 2014;2014:429031.
[PubMed]
23.
Häuser W, Dietz N, Grandt D, Steder-Neukamm U, Janke KH, Stein U, Stallmach A: Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis. Z Gastroenterol 2004;42:131-139.
[PubMed]
24.
Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-444.
[PubMed]
25.
Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298:82-86.
[PubMed]
26.
Hoffmann JC, Preiss JC, Autschbach F, Buhr HJ, Häuser W, Herrlinger K, Höhne W, Koletzko S, Krieglstein CF, Kruis W, Matthes H, Moser G, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Sido B, Siegmund B, Stallmach A, Bokemeyer B, Stange EF, Zeitz M: [Clinical practice guideline on diagnosis and treatment of Crohn's disease]. Z Gastroenterol 2008;46:1094-1146.
[PubMed]
27.
Halle M: Schritt für Schritt endlich fit: Das 10-Wochen-Programm. Munich, Wilhelm Goldmann Verlag, 2014.
28.
Hlavaty T, Persoons P, Vermeire S, Ferrante M, Pierik M, Van Assche G, Rutgeerts P: Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm Bowel Dis 2006;12:199-204.
[PubMed]
29.
Loudon CP, Corroll V, Butcher J, Rawsthorne P, Bernstein CN: The effects of physical exercise on patients with Crohn's disease. Am J Gastroenterol 1999;94:697-703.
[PubMed]
30.
Ng V, Millard W, Lebrun C, Howard J: Low-intensity exercise improves quality of life in patients with Crohn's disease. Clin J Sport Med 2007;17:384-388.
[PubMed]
31.
Elsenbruch S, Langhorst J, Popkirowa K, Müller T, Luedtke R, Franken U, Paul A, Spahn G, Michalsen A, Janssen OE, Schedlowski M, Dobos GJ: Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 2005;74:277-287.
[PubMed]
32.
Oliveira S, Zaltman C, Elia C, Vargens R, Leal A, Barros R, Fogaça H: Quality-of-life measurement in patients with inflammatory bowel disease receiving social support. Inflamm Bowel Dis 2007;13:470-474.
[PubMed]
33.
O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL; HF-ACTION Investigators: Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009;301:1439-1450.
[PubMed]
34.
Narula N, Fedorak RN: Exercise and inflammatory bowel disease. Can J Gastroenterol 2008;22:497-504.
[PubMed]
35.
Cosnes J: Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD. Dig Dis 2010;28:411-417.
[PubMed]
36.
Robinson RJ, Krzywicki T, Almond L, al-Azzawi F, Abrams K, Iqbal SJ, Mayberry JF: Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology 1998;115:36-41.
[PubMed]
37.
Packer N, Hoffman-Goetz L, Ward G: Does physical activity affect quality of life, disease symptoms and immune measures in patients with inflammatory bowel disease? A systematic review. J Sports Med Phys Fitness 2010;50:1-18.
[PubMed]
38.
Ploeger H, Obeid J, Nguyen T, Takken T, Issenman R, de Greef M, Timmons B: Exercise and inflammation in pediatric Crohn's disease. Int J Sports Med 2012;33:671-679.
[PubMed]
39.
Cook MD, Martin SA, Williams C, Whitlock K, Wallig MA, Pence BD, Woods JA: Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis. Brain Behav Immun 2013;33:46-56.
[PubMed]
40.
D'Incà R, Varnier M, Mestriner C, Martines D, D'Odorico A, Sturniolo GC: Effect of moderate exercise on Crohn's disease patients in remission. Ital J Gastroenterol Hepatol 1999;31:205-210.
[PubMed]
You do not currently have access to this content.